Neutrophil‐to‐Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries
Bahira Shahim(Karolinska University Hospital), Isaac George(Columbia University), Vasilis Babaliaros(Valve (United States)), Zachary M. Gertz(Virginia Commonwealth University), Ditian Li(Cardiovascular Research Foundation), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Susheel Kodali(Columbia University Irving Medical Center), Björn Redfors(Cornell University), Shmuel Chen(NewYork–Presbyterian Hospital), Sammy Elmariah(Brigham and Women's Hospital), Aaron Crowley(Cardiovascular Research Foundation), Brian R. Lindman(Washington University in St. Louis), Alan Zajarías(Washington University in St. Louis), Howard C. Herrmann(University of Pennsylvania), Torsten Dahlén(Karolinska University Hospital), Robert A. Guyton(Emory University), Samir Kapadia(Cleveland Clinic), David J. Cohen(Baim Institute for Clinical Research), Martin B. Leon(Columbia University Irving Medical Center), Vinod H. Thourani(Valve (United States)), Craig R. Smith(University of Arizona), Tamim Nazif(NewYork–Presbyterian Hospital)
Cited by 37
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k